Home » Healthcare » Pharmaceuticals » North America Vet Compounding Pharmacies Market

North America Vet Compounding Pharmacies Market By Product Type (CNS Agents, Anti-infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others); By Animal Type (Companion Animals, Livestock Animals); By Formulation (Oral, Injectable, Others); By Region (United States, Canada) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2999

Published: | Report ID: 34208 | Report Format : PDF
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
North America Vet Compounding Pharmacies Market Size 2023  USD 1,532 Million
North America Vet Compounding Pharmacies Market, CAGR  8.60%
North America Vet Compounding Pharmacies Market Size 2032  USD 3,526.48 Million

Market Overview

The North America veterinary compounding pharmacy market is projected to witness substantial growth, with its valuation expected to surge from USD 1,532 million in 2023 to USD 3,526.48 million by 2032, reflecting a remarkable compound annual growth rate of 8.60%. The North America veterinary compounding pharmacy market has emerged as a dynamic and rapidly evolving sector, driven by the increasing demand for customized medications tailored to the unique needs of animals. As pet ownership continues to rise and the awareness of veterinary healthcare expands, the market has witnessed substantial growth in recent years. This comprehensive overview explores key factors contributing to the market’s expansion, current trends, challenges, and future prospects.

One of the primary drivers of this market is the growing pet population across North America. As pets increasingly become integral members of households, owners are more willing to invest in their well-being, driving the demand for specialized veterinary medications. Moreover, the rising prevalence of chronic diseases in pets, similar to those affecting humans, has created a need for customized pharmaceutical solutions, further fueling the demand for compounding pharmacies.

A significant trend influencing the North America veterinary compounding pharmacy market is the shift towards personalized medicine for animals. Veterinarians and pet owners are recognizing the benefits of tailored medications, offering precise dosage and formulations based on individual animal characteristics. This trend aligns with the broader movement towards personalized healthcare, emphasizing the importance of customized treatments for optimal outcomes.

Technological advancements in compounding pharmacy practices also play a crucial role in shaping the market landscape. Innovations in drug delivery systems, formulations, and dosage forms enable compounding pharmacies to offer a diverse range of solutions to veterinarians, enhancing treatment options for various animal health conditions.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Segmentation Analysis

By Product Type:

Within the North America veterinary compounding pharmacy market, CNS agents stand out as a prominent product category. These agents, designed to affect the central nervous system of animals, address neurological disorders and contribute significantly to the market’s overall growth. Another pivotal segment is anti-infective agents, playing a crucial role in combating infections in both companion and livestock animals. The escalating prevalence of infectious diseases in the veterinary domain propels the demand for compounded anti-infective agents, contributing substantially to the market’s expansion. Hormones and substitutes form a critical segment in the veterinary compounding pharmacy market, catering to the specific hormonal needs of animals. As hormonal imbalances affect various physiological functions, the demand for compounded hormone treatments has witnessed a notable uptick, fostering growth within this product category. The anti-inflammatory agents segment addresses the pressing need for managing inflammation-related conditions in animals.

By Animal Type:

The segment dedicated to companion animals is a cornerstone of the veterinary compounding pharmacy market. As the bond between pets and their owners strengthens, the demand for customized medications for conditions ranging from chronic diseases to behavioral issues continues to rise. Livestock animals constitute a substantial segment within the market, driven by the imperative to maintain the health and productivity of agricultural and farming assets. Compounded medications for livestock animals address a spectrum of health concerns, including infectious diseases, hormonal imbalances, and nutritional deficiencies.

By Formulation:

The oral formulation segment holds a prominent position in the North America veterinary compounding pharmacy market. This mode of administration offers convenience and ease of dosage for both veterinarians and pet owners, contributing to the widespread adoption of compounded oral medications across various therapeutic categories. Injectable formulations cater to the need for immediate and targeted delivery of medications. This segment is particularly crucial in emergency situations and for conditions requiring rapid intervention.


By Product Type:

  • CNS Agents
  • Anti-infective Agents
  • Hormones and Substitutes
  • Anti-inflammatory Agents
  • Others

By Animal Type :

  • Companion Animals
  • Livestock Animals

By Formulation :

  • Oral
  • Injectable
  • Others

By Region

  • United States
  • Canada

Market Drivers

Rising Importance of Companion Animals:

The North American veterinary compounding pharmacy market is experiencing a significant paradigm shift driven by the escalating importance of companion animals. Pets are increasingly perceived as cherished family members, fostering a robust human-animal bond. This evolving perspective translates into a heightened willingness among pet owners to invest in comprehensive healthcare solutions, including compounded medications. As pets take on a more integral role in households, the demand for specialized veterinary pharmaceuticals tailored to their unique needs continues to rise, positioning the market for sustained growth.

Demand for Personalized Pet Care:

A pivotal driver propelling the North America veterinary compounding pharmacy market is the escalating demand for personalized pet care. Veterinarians are recognizing the imperative of customized treatment options to address the diverse and unique needs of individual pets, particularly those with specific allergies or sensitivities. Compounding pharmacies play a crucial role in this landscape by tailoring medications to precise dosages, flavors, and delivery methods, ensuring optimal efficacy while accommodating the preferences and health conditions of each patient. This surge in demand for tailored pet care solutions underscores the market’s adaptability and responsiveness to evolving veterinary healthcare trends.

Limited Availability of Commercially Available Medications:

The market is further fueled by the limited availability of commercially produced medications designed for pets. Certain pharmaceuticals necessary for effective veterinary treatment may not be readily available in suitable dosages or formats. Compounding pharmacies bridge this gap by formulating medications to meet the specific needs of various animal species. This flexibility and ability to cater to niche medical requirements position compounding pharmacies as indispensable contributors to the veterinary healthcare ecosystem.

Increasing Veterinary Expertise in Compounding:

A notable driver influencing the North America veterinary compounding pharmacy market is the increasing expertise and awareness among veterinarians regarding the benefits of compounded medications. More veterinary professionals are incorporating compounded pharmaceuticals into their treatment plans, recognizing the advantages of tailored solutions for diverse medical conditions. This growing familiarity among veterinarians not only stimulates the demand for compounding pharmacy services but also underscores the integral role compounding plays in enhancing the efficacy and precision of veterinary healthcare practices.

Rising Prevalence of Chronic Conditions in Pets:

The surge in chronic conditions among pets, mirroring trends observed in human healthcare, is another significant driver shaping the veterinary compounding pharmacy market. As pets live longer, they are increasingly susceptible to ailments such as diabetes, allergies, and arthritis. Compounded medications offer a viable solution by providing sustained and targeted treatment for these chronic conditions, thereby addressing a critical need in the evolving landscape of veterinary healthcare.

Growing Online Presence of Veterinary Pharmacies:

The market is witnessing a transformative shift with the growing online presence of veterinary pharmacies. The rise of online platforms facilitates easier access to compounded medications for pet owners, expanding the market reach for compounding pharmacies. This trend aligns with the broader digital transformation in healthcare, making it more convenient for pet owners to procure specialized medications, reinforcing the market’s growth trajectory.

Favorable Regulatory Landscape:

The North American regulatory environment provides a favorable backdrop for the growth of veterinary compounding pharmacies. Compared to some other regions, the regulatory landscape is conducive to easier operation and innovation within the market. This regulatory leniency fosters a more dynamic and responsive market, allowing compounding pharmacies to adapt to evolving healthcare needs and contribute significantly to the advancement of veterinary medicine in the region.

Market Trends

Specialization and Focus:

Compounding pharmacies within the veterinary landscape are increasingly honing their expertise by specializing in specific areas such as dermatology, pain management, or oncology. This strategic focus enables these pharmacies to cultivate deeper knowledge and proficiency, ultimately leading to the development of improved medication formulations. The tailored approach allows compounding pharmacies to better cater to the unique requirements of veterinarians and pet owners with specific healthcare needs. By specializing, these pharmacies contribute to the advancement of veterinary medicine by providing more nuanced and effective solutions.

Telepharmacy Services:

The evolution of telemedicine has extended its reach to veterinary care, giving rise to telepharmacy services. This innovative approach enables pet owners to consult with veterinarians online, facilitating remote diagnosis and treatment planning. Moreover, telepharmacy services offer the added convenience of having compounded medications delivered directly to pet owners’ homes. This not only enhances accessibility to veterinary care but also streamlines the medication acquisition process, contributing to improved overall pet healthcare.

Technological Advancements:

Compounding pharmacies are actively embracing technological advancements to enhance efficiency and accuracy in their operations. Automation is becoming increasingly prevalent in medication preparation, contributing to precision and consistency. Improved inventory management systems ensure the availability of essential pharmaceutical components, and online portals facilitate seamless electronic ordering for veterinarians. These technological integrations collectively elevate the capabilities of compounding pharmacies, positioning them at the forefront of innovation in the veterinary pharmaceutical landscape.

Focus on Flavoring and Palatability:

Recognizing the significance of palatability in ensuring treatment adherence for pets, compounding pharmacies are placing a heightened focus on developing innovative flavorings and formulations. Palatable medications play a crucial role in encouraging pets to complete their treatment plans, especially in cases of chronic conditions. By enhancing the appeal of medications, compounding pharmacies contribute to improved patient compliance, resulting in more effective and successful veterinary treatments.

Growing Focus on Natural and Organic Ingredients:

With an increasing demand for natural and organic pet products, compounding pharmacies are responding by incorporating these preferences into medication formulations. The use of natural and organic ingredients whenever possible aligns with the evolving preferences of pet owners. This trend reflects a commitment to meeting the expectations of a growing demographic of environmentally conscious and health-focused consumers, providing an additional dimension to the diverse offerings of compounding pharmacies.

Emphasis on Compliance and Safety:

Maintaining strict adherence to regulatory guidelines and best practices for compounding is a paramount focus within the veterinary pharmaceutical landscape. Compounding pharmacies prioritize robust quality control measures to ensure the safety and efficacy of compounded medications for pets. This commitment to compliance not only instills confidence among veterinarians and pet owners but also establishes compounding pharmacies as reliable partners in the delivery of safe and effective veterinary care.

Strategic Partnerships:

Collaboration between compounding pharmacies and veterinary practices is gaining prominence as a strategic approach to enhancing overall patient care. This collaborative model fosters better communication between pharmacists and veterinarians, streamlines workflows, and allows for the development of co-branded medication formulations. By forging these strategic partnerships, compounding pharmacies contribute to a more integrated and patient-centric approach to veterinary medicine, addressing specific patient needs and optimizing treatment outcomes.

Market Restraints and Challenges

Stricter Regulations:

While the regulatory environment for veterinary compounding pharmacies in North America is generally favorable, concerns about safety have led to instances of stricter regulations being implemented. This introduces a level of uncertainty within the industry, potentially limiting the development and availability of certain compounded medications. The need for compliance with evolving regulations presents a challenge for compounding pharmacies, necessitating ongoing adaptation to ensure adherence to safety standards and maintain the trust of veterinarians and pet owners.

Limited Insurance Coverage:

A significant hurdle facing pet owners is the limited coverage provided by most insurance plans for compounded medications. The absence of insurance support places the entire financial burden on pet owners, especially for long-term or expensive medications. This financial barrier can impede access to compounded pharmaceuticals, impacting the willingness of pet owners to explore these personalized treatment options. Addressing the issue of limited insurance coverage is essential to ensure broader accessibility to compounded medications for pet healthcare.

Potential for Medication Inconsistency:

The process of compounding medications introduces a level of variability compared to mass-produced drugs. Ensuring consistent quality and efficacy across batches demands strict adherence to compounding protocols and the implementation of robust quality control measures. The potential for medication inconsistency poses a challenge for compounding pharmacies, emphasizing the critical importance of maintaining high standards to guarantee the reliability and effectiveness of compounded medications.

Lack of Standardization:

The lack of standardization across compounding pharmacies in terms of practices and formulations poses a challenge for veterinarians seeking consistent quality. Variability in compounding practices can make it difficult for veterinarians to confidently rely on compounded medications from different providers. Establishing standardized practices and formulations within the industry is crucial to enhance the trust of veterinarians and ensure a consistent level of quality and safety across compounding pharmacy services.

Competition from Large Pharmaceutical Companies:

The presence of large pharmaceutical companies in the market introduces a competitive dynamic that compounding pharmacies must navigate. Some large pharmaceutical entities may perceive compounding pharmacies as a threat and actively lobby for stricter regulations or limitations on compounded medications. This can create an uneven playing field for smaller compounding pharmacies, challenging their ability to operate independently. Navigating this competitive landscape requires strategic approaches and advocacy to maintain the integrity and viability of compounding pharmacy services.

Need for Increased Awareness:

A critical challenge facing the veterinary compounding pharmacy market is the need for increased awareness among pet owners about the benefits and limitations of compounded medications. Many pet owners may not be fully informed about the potential advantages of personalized treatments or the considerations involved in choosing compounded medications. Educational efforts become paramount to bridge this knowledge gap, empowering pet owners to make informed decisions about whether compounded medications align with the specific healthcare needs of their pets. Greater awareness contributes to a more informed and engaged pet owner community, fostering a collaborative approach to veterinary care decisions.

Key Players

  • Hoye’s Pharmacy
  • Pace Pharmacy
  • Aurora Compounding
  • MEDS Canadian Compounding Pharmacy
  • Triangle Compounding Pharmacy Inc.
  • Victoria Compounding Pharmacy
  • Smith Caldwell Drug Store
  • Sixth Avenue Medical Pharmacy
  • Dougherty Pharmacy
  • Chiron Compounding Pharmacy
  • Vertisis Custom Pharmacy
  • People’s Choice Pharmacy
  • Pratt’s Compounding Pharmacy

Recent Developments

  • In February 2023, Wedgewood Pharmacy expanded its capabilities by acquiring Front Range Laboratories (FRL), a comprehensive testing facility located in Loveland, Colorado. FRL specializes in analytical and microbiological testing, along with product stability assessments, catering to the needs of pharmacies across the nation. Wedgewood Pharmacy has committed to maintaining the FRL brand, a testament to its esteemed reputation within the compounding pharmacy sector for delivering exceptional services.
  • In October 2022, Medisca announced its strategic initiative to lease a 60,000-square-foot facility in Plattsburgh, New York, dedicated to optimizing its distribution and packaging processes. This development underscores Medisca’s dedication to improving operational efficiency and expanding its infrastructure to better serve its clientele.
  • In September 2022, the Food and Drug Administration (FDA) finalize and release guidance on the compounding of animal treatments using bulk drug substances, initially introduced in April. This guidance, known as Guidance for Industry #256, outlines the scenarios in which the FDA will show leniency regarding certain violations of the Federal Food, Drug, and Cosmetic Act concerning drug approval, labeling, and manufacturing practices, specifically when drugs are compounded from bulk substances for animal patients by pharmacists and veterinarians.
  • March 2021 marked the launch of Revelation Pharma Corp by Osceola Capital, alongside seasoned entrepreneur Jacob Beckel. The corporation was established to explore investment opportunities and strategic partnerships within the pharmacy compounding arena.
  • The FDA issued an important guidance document, GFI #256, in January 2021. This document delineates the conditions under which the FDA intends to exercise enforcement discretion regarding regulations that could hinder the bulk production of medications. GFI #256 is designed to provide pharmaceutical manufacturers with clear insights into compliance expectations, thereby fostering a more transparent and flexible regulatory environment.
  • In December 2020, a significant partnership transition occurred as Wedgewood Pharmacy and Partners Group took over from New Harbor Capital to become the majority shareholders, signaling a new chapter in the company’s growth and development strategy.

Regional Analysis

United States: The United States dominates the North American veterinary compounding pharmacy market, accounting for a significant share of approximately 85%. This dominant position can be attributed to several factors, including a well-established veterinary healthcare infrastructure, a large population of companion animals, and a high level of pet ownership. The market in the United States is driven by the increasing demand for customized medications tailored to the unique needs of individual animals, as well as the growing awareness among pet owners about the benefits of compounded medications.

Furthermore, the presence of major compounding pharmacies and industry associations, such as the Professional Compounding Centers of America (PCCA) and the Alliance for Pharmacy Compounding (APC), has played a crucial role in promoting and regulating the compounding industry within the country. These organizations provide education, training, and advocacy efforts to ensure the quality and safety of compounded medications for veterinary use.

Canada: While the United States holds a dominant position, Canada represents a smaller but growing segment of the North American veterinary compounding pharmacy market, accounting for approximately 15% of the regional share. The Canadian market is characterized by a strong emphasis on animal welfare, a growing pet ownership culture, and increasing awareness about the benefits of customized medications for animals.

In Canada, veterinary compounding pharmacies operate under the oversight of provincial regulatory bodies, ensuring adherence to strict quality standards and best practices. The market is driven by the demand for specialized medications for various animal species, including companion animals, livestock, and exotic pets. Additionally, the availability of compounded medications has been instrumental in addressing drug shortages and providing alternative treatment options for veterinary practitioners.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  1. The North America vet compounding pharmacy market is poised for robust growth, driven by the escalating demand for personalized medications for companion and livestock animals.
  2. Advancements in technology, including automation and data analytics, are expected to enhance the efficiency and precision of compounding pharmacy processes, facilitating a more streamlined approach to medication formulation.
  3. The market is likely to witness an increased focus on developing innovative formulations and dosage forms to address the unique healthcare needs of diverse animal species.
  4. Growing awareness among veterinarians about the benefits of compounded medications is anticipated to contribute to the expanding integration of these customized treatments into veterinary care plans.
  5. The rise of online platforms in the veterinary pharmaceutical space is expected to extend the market reach, providing pet owners with easier access to compounded medications and contributing to market expansion.
  6. A continued emphasis on regulatory compliance and safety measures is crucial for sustaining the industry’s growth, ensuring the efficacy and quality of compounded medications for animals.
  7. Specialization within compounding pharmacies, particularly in areas like dermatology, pain management, and oncology, is likely to become more pronounced, catering to specific veterinary healthcare needs.
  8. Telepharmacy services are poised to play an increasingly significant role, offering pet owners the convenience of online consultations with veterinarians and direct delivery of compounded medications to their homes.
  9. The market may witness a shift towards natural and organic ingredients in compounded medications, aligning with the growing demand for pet products that prioritize health and environmental considerations.
  10. Strategic collaborations between compounding pharmacies and veterinary practices are expected to intensify, fostering improved communication, streamlined workflows, and the development of co-branded medication formulations to meet specific patient needs.

For Table OF Content – Request For Sample Report –

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Frequently Asked Questions:

What factors are contributing to the substantial growth of the North America veterinary compounding pharmacy market?

The market is witnessing significant expansion due to the increasing demand for customized medications tailored to the unique needs of animals, driven by the rising pet population and growing awareness of veterinary healthcare.

How is the North America veterinary compounding pharmacy market projected to evolve in terms of valuation from 2023 to 2032?

The market is expected to experience remarkable growth, with its valuation projected to surge from USD 1,532 million in 2023 to USD 3,526.48 million by 2032, reflecting an impressive compound annual growth rate of 8.60%.

What are the primary drivers fueling the demand for specialized veterinary medications in North America?

The growing pet population, where pets are increasingly considered integral family members, is a key driver. Additionally, the rising prevalence of chronic diseases in pets, akin to those in humans, is creating a demand for customized pharmaceutical solutions, thereby fueling the need for compounding pharmacies.

How are compounding pharmacies adapting to technological advancements in the veterinary pharmaceutical landscape?

Compounding pharmacies are actively embracing technological innovations such as automation, data analytics, and advancements in drug delivery systems. These technologies enhance the efficiency and precision of compounding pharmacy processes, offering a diverse range of solutions for various animal health conditions.

What challenges does the North America veterinary compounding pharmacy market face, particularly in terms of regulatory complexities?

The industry operates within a regulatory framework that demands strict compliance to ensure the safety and efficacy of compounded medications for animals. Navigating these regulatory complexities while meeting the increasing demand for customized pharmaceuticals poses a notable challenge for market players.

US Addiction Treatment Market

Report ID: 43690

Gaucher Disease Therapeutics Market

Report ID: 12699

Obesity Diabetes Drugs Market

Report ID: 43145

Trigeminal Neuralgia Treatment Market

Report ID: 11788

Pompe Disease Therapeutics Market

Report ID: 5989

Pre-Menstrual Syndrome Treatment Market

Report ID: 11248

Vial Adaptors for Reconstitution Drug Market

Report ID: 15561

Psychedelic Medicine Market

Report ID: 41606

Hospital Infection Prevention And Control Market

Report ID: 7217

Nanoparticle Formulation Market

Report ID: 41106

Animal Drug Compounding Market

Report ID: 40870

Antibiotics Market

Report ID: 40728

Purchase Options

Delivery Format: Excel.
Designed for the individual purchaser.
Users located at a single corporate site or regional office.
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


+91 6232 49 3207


24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN